Credit: Vertex. According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment. An additional 94 non-F508del CFTR mutations and a boxed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback